sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
Published 4 years ago • 29 plays • Length 6:06Download video MP4
Download video MP3
Similar videos
-
6:06
sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
-
2:02
sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
-
3:39
sacituzumab govitecan in previously treated metastatic urothelial carcinoma
-
2:38
trophy-u-01 cohort 3: sacituzumab govitecan pembrolizumab for patients with muc
-
3:53
sacituzumab govitecan in metastatic urothelial carcinoma: updates on the phase ii study
-
5:27
sacituzumab govitecan demonstrates metastatic urothelial cancer benefit | yohann loriot
-
4:54
sacituzumab govitecan for patients with advanced urothelial carcinoma
-
6:01
sacituzumab govitecan given accelerated fda approval for advanced urothelial cancer
-
1:18
dr. tagawa on next steps with sacituzumab govitecan in advanced urothelial carcinoma
-
1:10
use of sacituzumab govitecan in metastatic urothelial carcinoma
-
3:47
sacituzumab govitecan in mtnbc
-
2:17
sacituzumab govitecan with platinum chemotherapy: antitumor effects | oncotarget
-
4:04
efficacy of sacituzumab govitecan by trop-2 expression in metastatic urothelial carcinoma
-
3:54
biomarker analysis: sacituzumab govitecan vs chemotherapy in metastatic tpn breast cancer
-
1:38
dr. tagawa on sacituzumab govitecan in urothelial carcinoma
-
2:09
petros grivas on the efficacy of sacituzumab govitecan for bladder cancer
-
0:40
neoadjuvant sacituzumab govitecan for muscle-invasive bladder cancer
-
3:59
sacituzumab govitecan for treatment-refractory metastatic breast cancer
-
4:21
sacituzumab govitecan plus enfortumab vedotin in advanced urothelial cancer